Andrew Bolt

In this conversation, Andrew Bolt, a commentator from Sky News known for his critical views on media narratives, joins to discuss Tucker Carlson’s controversies and his upcoming tour in Australia. They delve into the inconsistent treatment of artists based on their backgrounds, sparking debates about free speech. There's an exploration of media biases against conservative values, especially surrounding Trump’s remarks on IVF. The discussion champions independent thought against mainstream media's challenges in presenting genuine political dialogue.

AI in R&D for life sciences is transforming drug targeting, patient recruitment, and regulatory compliance. Advancements in AI-enhanced protein structure prediction are revolutionizing the industry. The impact of AI on drug discovery, clinical trials, and regulatory functions is discussed, highlighting the potential for innovation and efficiency in the pharmaceutical field.